OPTICYTE INC
The World's Only Cell O₂ Monitor
SEATTLE, United States · Founded 2015 · $4.6M raised
- Headquarters
- SEATTLE, Washington
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- opticyte.com
- Total Funding
- $4.6M
- Last Round
- $4.6M AngelDec 2024
- Rounds
- 2
About
Opticyte is a University of Washington spinout developing the world's first Cell O₂ Monitor, the VitalO₂, designed to detect cellular oxygen levels in real time to reduce organ failure and death from sepsis. Founded in 2016, the company has secured over $4M in non-dilutive NIH SBIR/STTR funding and angel investments, and received FDA Breakthrough Device Designation for its patient monitor.
Summary
OPTICYTE INC is a Biotech company based in SEATTLE, United States, founded in 2015. It has raised $4.6M in total across 2 rounds, most recently a $4.6M Angel round in Dec 2024. Investors include SWAN Venture Fund.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...